+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

ePharmacy Market Size, Share & Trends Analysis Report by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • April 2022
  • Region: Global
  • Grand View Research
  • ID: 5440488
The global ePharmacy market size is expected to reach USD 249.9 billion by 2030 and is expected to grow at a CAGR of 19.5% over the forecast period. Factors driving the adoption of ePharmacy include the improved access to online & web-based services, increasing awareness regarding e-commerce among consumers, rise in the number of internet users, and a surge in the aging population experiencing difficulty to visit pharmacies. In addition, benefits, such as affordability, convenience, and ease in the availability of medicines, are boosting the adoption of these platforms. High treatment costs are driving the demand for low-cost healthcare services, which, in turn, is bolstering the adoption of online pharmacies owing to the lucrative offers, such as price discounts, provided by them.



The COVID-19 pandemic has positively impacted the market growth and transformed the fortunes of ePharma companies owing to increasing consumer switch from traditional buying towards online purchases of general medications and medical devices, such as oximeters, thermometers, and health supplements. As per an article published by Economic Times in July 2021, the number of households utilizing ePharmacy services grew 2.5 times to 9.0 million during the pandemic. Moreover, the second wave of the Covid-19 epidemic has prompted a spike in demand for medical gadgets, personal protective equipment (PPE), as well as health supplements, and frequently accessible medications in the market.

In September 2020, UnitedHealth, purchased startup DivvyDose, a key player in the ePharmacy industry. DivvyDose, a competition to Amazon-owned PillPack, has been bought by UnitedHealth Group. Thus, the ePharmacy segment has also gained significant growth during the post lockdown period, as governments encouraged the delivery of medicines through e-commerce platforms as an essential service.

ePharmacy Market Report Highlights

  • North America dominated the market in 2021 owing to the increased prevalence of chronic diseases, developed healthcare infrastructure, and penetration of IT in healthcare across the region. According to Clarivate Analytics, the usage of internet pharmacies has climbed by 17% in the U.S. during the previous year. Consumers aged 18 to 34 are the most likely to use it.
  • Industry players in this market have significantly expanded their customer base as well as their product & service offerings to keep up with the growing needs of the consumers. As a result, in 2021 March, One of the U.K.'s digital prescription businesses has been bought by the corporation that runs the Rowlands drugstore chain and the Numark pharmacy membership business.
  • The main focus of these players is on increasing the Customer Lifetime Value (CLTV) by catering to their healthcare needs in a comprehensive manner, as various online pharmacies have started offering additional services like e-diagnostics, e-consultation, and retailing of health & wellness products.
  • Furthermore, a rise in the number of strategic initiatives is aiding market growth. For instance, in August 2020, Amazon India announced the launch of Amazon Pharmacy in Bengaluru, India. In June 2021, PharmEasy is purchasing a controlling share in Thyrocare Technologies, a diagnostics company. This alliance will provide huge potential and synergies for the whole Indian healthcare ecosystem of customers, physicians, and suppliers.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Process
1.2 Information Procurement
1.2.1 Purchased database
1.2.1.1 internal database
1.2.2 Market Formulation & Validation
1.3 Research Methodology
1.4 Research Scope and Assumptions
1.5 Research Methodology
1.5.1 Region Market: CAGR Calculation
1.5.2 Region-based Segment Share Calculation
1.6 List to Data Nutrient Type
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 ePharmacy market Snapshot
Chapter 3 ePharmacy Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Penetration and Growth Prospect Mapping
3.3 ePharmacy Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.4 ePharmacy Market Analysis Tools
3.4.1 Industry Analysis-Porter's
3.4.1.1 Bargaining power of suppliers
3.4.1.2 Bargaining power of the buyers
3.4.1.3 Threat of substitution
3.4.1.4 Threats of new entrants
3.4.1.5 Competitive rivalry
3.4.2 PESTLE Analysis
3.4.2.1 Political and Legal Landscape
3.4.2.2 Economic and Social Landscape
3.4.2.3 Environment and Technology Landscape
3.5 Impact of COVID-19 on the ePharmacy market
Chapter 4 ePharmacy Market: Regional Estimates & Trend Analysis
4.1 Regional market snapshot (USD Million)
4.2 ePharmacy market: regional movement analysis, 2021 & 2030 (USD Million)
4.3 North America
4.3.1 North America ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.3.2 U.S.
4.3.2.1 U.S. ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.3.3 Canada
4.3.3.1 Canada ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.4 Europe
4.4.1 Europe ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.4.2 Germany
4.4.2.1 Germany ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.4.3 U.K.
4.4.3.1 U.K. ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.4.4 Italy
4.4.4.1 Italy ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.4.5 Spain
4.4.5.1 Spain ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.4.6 France
4.4.6.1 France ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.4.7 Russia
4.4.7.1 Russia ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.5 Asia Pacific
4.5.1 Asia Pacific ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.5.2 Japan
4.5.2.1 Japan ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.5.3 China
4.5.3.1 China ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.5.4 India
4.5.4.1 India ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.5.5 Australia
4.5.5.1 Australia ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.5.6 Singapore
4.5.6.1 Singapore ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.5.7 South Korea
4.5.7.1 South Korea ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.6 Latin America
4.6.1 Latin America ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.6.2 Brazil
4.6.2.1 Brazil ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.6.3 Mexico
4.6.3.1 Mexico ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.6.4 Argentina
4.6.4.1 Argentina ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.7 MEA
4.7.1 MEA ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.7.2 South Africa
4.7.2.1 South Africa ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.7.3 Saudi Arabia
4.7.3.1 Saudi Arabia ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
4.7.4 UAE
4.7.4.1 UAE ePharmacy market estimates and forecasts, 2017-2030 (USD Million)
Chapter 5 ePharmacy market: Competitive Analysis
5.1 Recent Developments & Impact Analysis, by Key Market Participants
5.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
5.3 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
Chapter 6 Competitive Landscape
6.1 Company Profiles
6.1.1 The Kroger Co.
6.1.1.1 Company overview
6.1.1.2 Financial performance
6.1.1.3 Product benchmarking
6.1.1.4 Strategic initiatives
6.1.2 Walgreen Co.
6.1.2.1 Company overview
6.1.2.2 Financial performance
6.1.2.3 Product benchmarking
6.1.2.4 Strategic initiatives
6.1.3 Giant Eagle, Inc.
6.1.3.1 Company overview
6.1.3.2 Financial performance
6.1.3.3 Product benchmarking
6.1.3.4 Strategic initiatives
6.1.4 Walmart, Inc.
6.1.4.1 Company overview
6.1.4.2 Financial performance
6.1.4.3 Product benchmarking
6.1.4.4 Strategic initiatives
6.1.5 Express Scripts Holding Company
6.1.5.1 Company overview
6.1.5.2 Financial performance
6.1.5.3 Product benchmarking
6.1.5.4 Strategic initiatives
6.1.6 CVS Health
6.1.6.1 Company overview
6.1.6.2 Financial performance
6.1.6.3 Product benchmarking
6.1.6.4 Strategic initiatives
6.1.7 OptumRx, Inc.
6.1.7.1 Company overview
6.1.7.2 Financial performance
6.1.7.3 Product benchmarking
6.1.7.4 Strategic initiatives
6.1.8 Rowlands Pharmacy
6.1.8.1 Company overview
6.1.8.2 Financial performance
6.1.8.3 Product benchmarking
6.1.8.4 Strategic initiatives
6.1.9 DocMorris (Zur Rose Group AG)
6.1.9.1 Company overview
6.1.9.2 Financial performance
6.1.9.3 Product benchmarking
6.1.9.4 Strategic initiatives

Companies Mentioned

  • The Kroger Co.
  • Walgreen Co.
  • Giant Eagle, Inc.
  • Walmart, Inc.
  • Express Scripts Holding Company
  • CVS Health
  • OptumRx, Inc.
  • Rowlands Pharmacy
  • DocMorris (Zur Rose Group AG)

Methodology

Loading
LOADING...

Table Information